| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 290.716 | 87 |
| GSM780708 | Untreated after 4 days (C2_1) | 217.651 | 84 |
| GSM780709 | Untreated after 4 days (C3_1) | 244.658 | 86 |
| GSM780719 | Untreated after 4 days (C1_2) | 272.93 | 87 |
| GSM780720 | Untreated after 4 days (C2_2) | 222.509 | 85 |
| GSM780721 | Untreated after 4 days (C3_2) | 244.538 | 86 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 204.79 | 84 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 278.207 | 87 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 251.763 | 86 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 209.41 | 84 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 247.519 | 86 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 260.491 | 86 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 289.832 | 87 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 239.853 | 85 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 290.797 | 87 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 291.208 | 87 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 257.76 | 86 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 268.977 | 86 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 260.818 | 86 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 281.489 | 87 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 256.621 | 86 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 268.371 | 86 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 221.463 | 85 |